Keyphrases
Serum Protein Markers
100%
Type 1 Diabetes Mellitus (T1DM)
50%
Mass Spectrometry Methods
50%
Autoantibodies
40%
Type I Diabetes
40%
Predictive Marker
20%
Surface-enhanced Laser Desorption/ionization Time-of-flight Mass Spectrometry (SELDI-TOF-MS)
20%
Early Disease Prevention
20%
High-throughput Characterization
20%
Pandas
10%
Clinical Trials
10%
Serum Proteomics
10%
Serum Samples
10%
Protein Biomarker Discovery
10%
Low Sensitivity
10%
Approaches to Study
10%
Individuals at Risk
10%
High Concentration
10%
High-throughput Methods
10%
Large Cohort
10%
Protein Markers
10%
Novel Protein
10%
High Reproducibility
10%
Number of Subjects
10%
Metabolic
10%
Early Prediction
10%
False Positive Rate
10%
Antibody-negative
10%
Mass Spectrometry Platform
10%
Potential Biomarkers
10%
Islet Cells
10%
High Specificity
10%
Diabetic
10%
Modern Technologies
10%
Pharmacology, Toxicology and Pharmaceutical Science
Plasma Protein
100%
Biological Marker
100%
Autoantibodies
80%
Insulin Dependent Diabetes Mellitus
80%
Disease
40%
Cell Antigen
20%
Antigen
20%
Clinical Trial
20%
Biochemistry, Genetics and Molecular Biology
Mass Spectrometry
100%
Autoantibodies
100%
Plasma Protein
100%
Genetics
25%
Proteomics
25%
Biomarker Discovery
25%
Clinical Trial
25%